Biventricular pacing-induced acute response in baroreflex sensitivity has predictive value for midterm response to cardiac resynchronization therapy

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 297, Issue 1, 2009, Pages

  Gademan, Maaike G J ^a   Van Bommel, Rutger J ^a   Borleffs, C Jan Willem ^a   Man, SumChe ^a   Haest, Joris C W ^a   Schalij, Martin J ^a   Van Der Wall, Ernst E ^a   Bax, Jeroen J ^a   Swenne, Cees A ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Arterial baroreflex; Heart failure; Heart rate variability; Pacing

Indexed keywords

ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RATE VARIABILITY; HEART VENTRICLE REMODELING; HUMAN; MALE; OUTCOME ASSESSMENT; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; PROGNOSIS;

AGED; BAROREFLEX; BLOOD PRESSURE; CARDIAC PACING, ARTIFICIAL; ECHOCARDIOGRAPHY; FEMALE; HEART; HEART FAILURE; HEART RATE; HEART VENTRICLES; HUMANS; MALE; MIDDLE AGED; PACEMAKER, ARTIFICIAL; PREDICTIVE VALUE OF TESTS; PROSTHESIS IMPLANTATION; ROC CURVE; TREATMENT OUTCOME;

EID: 67650088300     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00113.2009     Document Type: Article

References (35)

1. Abraham WT, Fisher WG, Smith AL, Delurgio DB, Leon AR, Loh E, Kocovic DZ, Packer M, Clavell AL, Hayes DL, Ellestad M, Trupp RJ, Underwood J, Pickering F, Truex C, McAtee P, Messenger J. Cardiac resynchronization in chronic heart failure. N Engl J Med 346: 1845-1853, 2002.
2. Bader H, Garrigue S, Lafitte S, Reuter S, Jais P, Haissaguerre M, Bonnet J, Clementy J, Roudaut R. Intra-left ventricular electromechanical asynchrony. A new independent predictor of severe cardiac events in heart failure patients. J Am Coll Cardiol 43: 248-256, 2004.
3. Bax JJ, Ansalone G, Breithardt OA, Derumeaux G, Leclercq C, Schalij MJ, Sogaard P, St John SM, Nihoyannopoulos P. Echocardiographic evaluation of cardiac resynchronization therapy: ready for routine clinical use? A critical appraisal. J Am Coll Cardiol 44: 1-9, 2004.
4. Bax JJ, Bleeker GB, Marwick TH, Molhoek SG, Boersma E, Steendijk P, van der Wall EE, Schalij MJ. Left ventricular dyssynchrony predicts response and prognosis after cardiac resynchronization therapy. J Am Coll Cardiol 44: 1834-1840, 2004.
5. Bleeker GB, Bax JJ, Fung JW, van der Wall EE, Zhang Q, Schalij MJ, Chan JY, Yu CM. Clinical versus echocardiographic parameters to assess response to cardiac resynchronization therapy. Am J Cardiol 97: 260-263, 2006.
6. Boriani G, Regoli F, Saporito D, Martignani C, Toselli T, Biffi M, Francolini G, Diemberger I, Bacchi L, Rapezzi C, Ferrari R, Branzi A. Neurohormones and inflammatory mediators in patients with heart failure undergoing cardiac resynchronization therapy: time courses and prediction of response. Peptides 27: 1776-1786, 2006.
7. Braun MU, Rauwolf T, Zerm T, Schulze M, Schnabel A, Strasser RH. Long term biventricular resynchronisation therapy in advanced heart failure: effect on neurohormones. Heart 91: 601-605, 2005.
8. Burri H, Sunthorn H, Somsen A, Fleury E, Stettler C, Shah D, Righetti A. Improvement in cardiac sympathetic nerve activity in responders to resynchronization therapy. Europace 10: 374-378, 2008.
9. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 352: 1539-1549, 2005.
10. Frederiks J, Swenne CA, Ten Voorde BJ, Honzikova N, Levert JV, Maan AC, Schalij MJ, Bruschke AV. The importance of high-frequency paced breathing in spectral baroreflex sensitivity assessment. J Hypertens 18: 1635-1644, 2000.
11. Gademan MG, van Bommel RJ, Ypenburg C, Haest JC, Schalij MJ, van der Wall EE, Bax JJ, Swenne CA. Biventricular pacing in chronic heart failure acutely facilitates the arterial baroreflex. Am J Physiol Heart Circ Physiol 295: H755-H760, 2008.
12. Gao L, Schultz HD, Patel KP, Zucker IH, Wang W. Augmented input from cardiac sympathetic afferents inhibits baroreflex in rats with heart failure. Hypertension 45: 1173-1181, 2005.
13. Hamdan MH, Zagrodzky JD, Joglar JA, Sheehan CJ, Ramaswamy K, Erdner JF, Page RL, Smith ML. Biventricular pacing decreases sympathetic activity compared with right ventricular pacing in patients with depressed ejection fraction. Circulation 102: 1027-1032, 2000.
14. Lipkin DP, Scriven AJ, Crake T, Poole-Wilson PA. Six minute walking test for assessing exercise capacity in chronic heart failure. Br Med J 292: 653-655, 1986.
15. Menardi E, Vado A, Rossetti G, Racca E, Conte E, Deorsola A, Bobbio M, Feola M. Cardiac resynchronization therapy modifies the neurohormonal profile, hemodynamic and functional capacity in heart failure patients. Arch Med Res 39: 702-708, 2008.
16. Mortara A, La Rovere MT, Pinna GD, Prpa A, Maestri R, Febo O, Pozzoli M, Opasich C, Tavazzi L. Arterial baroreflex modulation of heart rate in chronic heart failure: clinical and hemodynamic correlates and prognostic implications. Circulation 96: 3450-3458, 1997.
17. Najem B, Unger P, Preumont N, Jansens JL, Houssiere A, Pathak A, Xhaet O, Gabriel L, Friart A, De Roy L, Vandenbossche JL, van de Borne P. Sympathetic control after cardiac resynchronization therapy: responders versus nonresponders. Am J Physiol Heart Circ Physiol 291: H2647-H2652, 2006.
18. Pan HL, Longhurst JC, Eisenach JC, Chen SR. Role of protons in activation of cardiac sympathetic C-fibre afferents during ischaemia in cats. J Physiol 518: 857-866, 1999.
19. Piepoli MF, Villani GQ, Corra U, Aschieri D, Rusticali G. Time course of effects of cardiac resynchronization therapy in chronic heart failure: benefits in patients with preserved exercise capacity. Pacing Clin Electrophysiol 31: 701-708, 2008.
20. Rector TS, Kubo SH, Cohn JN. Validity of the Minnesota Living with Heart Failure questionnaire as a measure of therapeutic response to enalapril or placebo. Am J Cardiol 71: 1106-1107, 1993.
21. Sarzi BS, La Rovere MT, Pedretti RF. Baroreflex sensitivity normalization after cardiac resynchronization therapy. Int J Cardiol 109: 118-120, 2006.
22. Saxon LA, Ellenbogen KA. Resynchronization therapy for the treatment of heart failure. Circulation 108: 1044-1048, 2003.
23. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, Gutgesell H, Reichek N, Sahn D, Schnittger I. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 2: 358 -367, 1989.
24. Seifert M, Schlegl M, Hoersch W, Fleck E, Doelger A, Stockburger M, Butter C. Functional capacity and changes in the neurohormonal and cytokine status after long-term CRT in heart failure patients. Int J Cardiol 121: 68 -73, 2007.
25. Stanton T, Hawkins NM, Hogg KJ, Goodfield NE, Petrie MC, McMurray JJ.How should we optimize cardiac resynchronization therapy? Eur Heart J 2008.
26. Sundell J, Engblom E, Koistinen J, Ylitalo A, Naum A, Stolen KQ, Kalliokoski R, Nekolla SG, Airaksinen KE, Bax JJ, Knuuti J. The effects of cardiac resynchronization therapy on left ventricular function, myocardial energetics, and metabolic reserve in patients with dilated cardiomyopathy and heart failure. J Am Coll Cardiol 43: 1027-1033, 2004.
27. Swenne CA, Frederiks J, Fischer PH, Hardeman WFC, Immerzeel-Geerlings MAC, Ten Voorde BJ. Noninvasive baroreflex sensitivity assessment in geriatric patients: feasability and role of the coherence criterion. Comput Cardiol 27: 45-48, 2000.
28. Tjen ALS, Bonham A, Longhurst JC. Interactions between sympathetic and vagal cardiac afferents in nucleus tractus solitarii. Am J Physiol Heart Circ Physiol 272: H2843-H2851, 1997.
29. Tjen ALS, Pan HL, Longhurst JC. Endogenous bradykinin activates ischaemically sensitive cardiac visceral afferents through kinin B2 receptors in cats. J Physiol 510: 633-641, 1998.
30. van de Vooren H, Gademan MGJ, Haest JCW, Schalij MJ, van der Wall EE, Swenne CA. Non-invasive baroreflex sensitivity assessment in heart failure patients with frequent episodes of non-sinus rhythm. Comput Cardiol 33: 637-640, 2006.
31. Waggoner AD, Faddis MN, Gleva MJ, De Las FL, Osborn J, Heuerman S, Davila-Roman VG. Cardiac resynchronization therapy acutely improves diastolic function. J Am Soc Echocardiogr 18: 216-220, 2005.
32. Wang W, Ma R. Cardiac sympathetic afferent reflexes in heart failure. Heart Fail Rev 5: 57-71, 2000.
33. Ypenburg C, van Bommel RJ, Borleffs CJ, Bleeker GB, Boersma E, Schalij MJ, Bax JJ. Long-term prognosis after cardiac resynchronization therapy is related to the extent of left ventricular reverse remodeling at midterm follow-up. J Am Coll Cardiol 53: 483-490, 2009.
34. Yu CM, Bleeker GB, Fung JW, Schalij MJ, Zhang Q, van der Wall EE, Chan YS, Kong SL, Bax JJ. Left ventricular reverse remodeling but not clinical improvement predicts long-term survival after cardiac resynchronization therapy. Circulation 112: 1580-1586, 2005.
35. 2 attenuates baroreflex control of renal nerve activity by a vagal mechanism. Am J Physiol Regul Integr Comp Physiol 254: R424-R430, 1988.